Company profile: Sirion Biotech
1.1 - Company Overview
Company description
- Provider of AAV, lentiviral, and adenoviral vectors for gene and cell therapy and vaccine development, including in vivo gene therapy for rare genetic diseases and ex vivo CAR-T applications; offers vector optimization (capsid/backbone, expression cassette), LentiBOOST transduction enhancer, custom viral vector engineering and manufacturing for research/preclinical, and GMP alliances via a global CDMO network.
Products and services
- Adenoviral Vectors for Vaccination: High-capacity adenoviral vectors used for gene therapies and vaccine development, offering high transgene expression and large packaging capacity
- AAV Vectors for Gene Therapy: Recombinant AAV vectors deployed for in vivo gene therapy to treat rare genetic diseases, enabling therapeutic expression cassette optimization, capsid selection, and manufacturing technologies
- Lentiviral Vectors for Cell Therapy: Ex vivo–designed lentiviral vectors for gene therapy, including CAR-T applications, featuring vector backbone optimization, therapeutic expression cassette development, and surface modification
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Sirion Biotech
Wacker Chemie
HQ: Germany
Website
- Description: Provider of silicone products (emulsions, rubber, silica) for electronics and automotive; polymer solutions for construction, adhesives and coatings; high-purity polysilicon for semiconductor and solar; biotechnology products and services including biopharmaceuticals and food ingredients; plus technical competence centers offering expert advice and product development support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Wacker Chemie company profile →
Lotus Clinical Research
HQ: United States
Website
- Description: Provider of full-service CRO services and a network of 20+ wholly-owned US clinical research sites for analgesic programs and trials in psychiatry, neurology, pain, and addiction. Services include project management, site selection and monitoring, EDC and data management, biostatistics, medical monitoring, medical writing, quality operations, placebo response mitigation, global rater training, scientific consultation, and metabolic disease trial support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lotus Clinical Research company profile →
PharmaCell
HQ: The Netherlands
Website
- Description: Provider of GMP-certified cell-culturing and contract manufacturing services for cellular therapies and regenerative medicine in Europe, operating facilities in Maastricht and Geleen. Serves world-leading commercial cell therapy companies and offers support or partnership to R&D companies through an extensive network.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaCell company profile →
PackGene
HQ: United States
Website
- Description: Provider of CRO/CDMO services for gene and cell therapy, specializing in AAV vectors, mRNA, plasmid DNA, and lentiviral solutions. Offerings include AAV vector design and construction; small- to large-scale AAV production up to GMP; π-Icosa serotype screening; Express Gene-to-AAV from synthesis to packaging; and on-demand gene editing mRNAs (e.g., Cas9). Supports discovery, preclinical, and trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PackGene company profile →
Inamed
HQ: Germany
Website
- Description: Provider of aerosol biophysics and technology with more than 30 years of experience.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inamed company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Sirion Biotech
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Sirion Biotech
2.2 - Growth funds investing in similar companies to Sirion Biotech
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Sirion Biotech
4.2 - Public trading comparable groups for Sirion Biotech
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →